CTSS and ovarian carcinoma: For instance, Oldak et al. proposed two analytically specific SPRi biosensors for measuring the levels of cathepsin S in diagnosing ovarian cancer, thereby solidifying the role of cathepsin S as an ovarian cancer biomarker.